ETP on Saxo Healthcare Innovation Select Equity NTR 129209210 / CH1292092108
20.71
CHF
-0.12
CHF
-0.58 %
17:41:46
NAV
| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Sharpe Ratio | ||
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
| 21.24 CHF | 0.06 CHF | 0.28 % |
|---|
| Vortag | 21.18 CHF | Datum | 07.07.2026 |
ETP on Saxo Healthcare Innovation Select Equity NTR Kurs - 1 Jahr
Anzeige
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 97.66% | |
| 21Shares Injective Staking ETP | CH1360612134 | 66.37% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 64.46% | |
| 21Shares Jupiter ETP | CH1480821383 | 51.86% | |
| 21Shares Pendle ETP | CH1495416997 | 48.43% | |
| 21shares Gram Staking ETP | CH1297762812 | 38.48% | |
| 21Shares Ondo ETP | CH1396389921 | 30.96% | |
| 21Shares Stellar ETP | CH1109575535 | 23.01% | |
| 21shares Jito Staked SOL ETP USD | CH1521714696 | 3.61% | |
| 21Shares Immutable ETP | CH1360612142 | 2.38% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 167.02% | |
| 21shares Canton Network ETP | CH1503127917 | 63.46% | |
| 21shares Morpho ETP | CH1506167027 | 62.06% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 12.88% | |
| 21Shares Jupiter ETP | CH1480821383 | 9.48% | |
| 21shares Gram Staking ETP | CH1297762812 | -9.76% | |
| 21Shares Injective Staking ETP | CH1360612134 | -11.25% | |
| 21Shares Bittensor ETP | CH1495416971 | -22.91% | |
| 21Shares Pendle ETP | CH1495416997 | -32.30% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -44.37% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Bitcoin Gold ETP | CH1146882308 | -0.45% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | -5.95% | |
| 21Shares Binance BNB ETP | CH0496454155 | -14.56% | |
| 21Shares Stellar ETP | CH1109575535 | -25.52% | |
| 21Shares Ethereum Core Staking ETP Acc | CH1209763130 | -29.28% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -29.31% | |
| 21Shares Injective Staking ETP | CH1360612134 | -55.93% | |
| 21Shares Dogecoin ETP | CH1431521033 | -56.72% | |
| 21Shares Immutable ETP | CH1360612142 | -67.72% | |
| 21Shares Sui Staking ETP | CH1360612159 | -74.62% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares XRP ETP | CH0454664043 | 154.61% | |
| 21Shares Stellar ETP | CH1109575535 | 117.97% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 53.45% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 37.72% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | 12.68% |
Fundamentaldaten
| Valor | 129209210 |
| ISIN | CH1292092108 |
| Emittent | LEONTEQ SECURITIES |
| Aufgelegt in | Switzerland |
| Auflagedatum | 30.09.2025 |
| Kategorie | Branchen: Biotechnologie |
| Währung | CHF |
| Volumen | |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 03.07.2026 |
Anlagepolitik
So investiert der ETP on Saxo Healthcare Innovation Select Equity NTR: The objective of this instrument is to provide exposure to companies advancing biotechnology, genomics, and personalised healthcare solutions. The selection includes firms engaged in genetic research, diagnostics, life-science tools, and innovative biopharmaceutical development. The instrument seeks to reflect the long-term potential of healthcare innovation as a driver of improved medical outcomes and industry transformation. Returns may be influenced by regulatory decisions, clinical results, ethical considerations, and market conditions.
ETP Performance: ETP on Saxo Healthcare Innovation Select Equity NTR
| Performance 1 Jahr | - | |
| Performance 2 Jahre | - | |
| Performance 3 Jahre | - | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |